Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mairah T. Khan"'
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Hypoxia is common in non-small cell lung cancer (NSCLC) and an attractive therapeutic target. As hypoxia-targeting treatments are effective in patients with the most hypoxic tumours, we aimed to develop a lung adenocarcinoma (LUAD) hypoxia-r
Externí odkaz:
https://doaj.org/article/a82709c4899e401bb9ed746ef62f412b
Autor:
Mairah T. Khan, Lars Dyrskjøt, Ronnie Rodrigues Pereira, Joely J. Irlam-Jones, Kai Aragaki, Helen R Valentine, Ananya Choudhury, Peter Hoskin, Brian Lane, Catharine M L West, David J. McConkey
Publikováno v:
Khan, M T, Irlam-Jones, J J, Pereira, R R, Lane, B, Valentine, H R, Aragaki, K, Dyrskjøt, L, McConkey, D J, Hoskin, P J, Choudhury, A & West, C M L 2021, ' A miRNA signature predicts benefit from addition of hypoxia-modifying therapy to radiation treatment in invasive bladder cancer ', British Journal of Cancer, vol. 125, no. 1, pp. 85-93 . https://doi.org/10.1038/s41416-021-01326-9
British Journal of Cancer
British Journal of Cancer
Background miRNAs are promising biomarkers in oncology as their small size makes them less susceptible to degradation than mRNA in FFPE tissue. We aimed to derive a hypoxia-associated miRNA signature for bladder cancer. Methods Taqman miRNA array car
Autor:
Catharine M L West, Joely J. Irlam-Jones, Helen R Valentine, Elisabet More, Mairah T. Khan, Peter Hoskin, Lingjian Yang, Ananya Choudhury
Publikováno v:
Radiation research. 195(4)
Long non-coding RNAs (lncRNAs) are involved in diverse biological processes, including DNA damage repair, and are of interest as potential biomarkers of radiosensitivity. We investigated whether lncRNA radiosensitivity signatures could be derived for